Inspire Medical Systems this week set the range for a proposed initial public offering that would fetch $75 million at the midpoint. Maple Grove, Minn.-based Inspire, which spun out from Medtronic (NYSE:MDT) in 2007, makes devices for treating obstructive sleep apnea. The company said it plans to issue 5 million shares at $14 to $16 apiece, setting its […]
Inspire Medical plans $86m IPO
Inspire Medical Systems, which spun out from Medtronic (NYSE:MDT) in 2007 and creates devices for treating obstructive sleep apnea, said last Friday it is looking to launch an initial public offering that could bring in as much as $86.3 million for the company. Inspire Medical developed and produces a sleep apnea implant, a pacemaker-like system designed to […]
Medtronic spinout Inspire Medical closes $38m Series F
Inspire Medical Systems, which spun out from Medtronic (NYSE:MDT) in 2007, said yesterday it closed a $37.5 million Series F financing round, as well as announcing the appointment of Marilyn Nelson to the board of directors. Inspire Medical developed and produces a sleep apnea implant, a pacemaker-like system designed to stimulate nerves to keep airways […]
Inspire Medical Systems raises $13m for sleep apnea device
Inspire Medical Systems has raised $12.5 million in a new round of equity financing, according to an SEC filing posted today. Inspire Medical developed and produces a sleep apnea implant, a pacemaker-like system designed to stimulate nerves to keep airways open during sleep. Good sleep is necessary for cpap and can affect hormone levels, mood […]
Medtech investment hits 6-year high in Minnesota
Investment in Minnesota’s thriving medtech scene hit a 6-year high in 2014 and the state saw a significant jump in pharma/biotech investments, according to LifeScience Alley’s annual report.
Medrobotics raises $26 million in a Series E fundraising round for Flex surgical robot | Medtech funding stories for the week of May 12, 2014
Inspire Medical raises $40M on launch of new sleep apnea implant
Minnesota-based Inspire Medical raised $40 million in a Series E financing round that the company timed to coincide the launch of its sleep apnea implant.
Medtronic spinout Inspire Medical lands FDA win for 1st sleep apnea implant
Report: FDA panel recommends Inspire Medical’s sleep apnea implant
Updated February 24, 2014, with details from Inspire Medical.
An expert panel of FDA advisors voted today to recommend approval for Inspire Medical’s sleep apnea implant, the Inspire II Upper Airway Stimulator, the company confirmed.
FDA reviews adverse events, durability of Inspire Medical’s sleep apnea implant
Minnesota-based Inspire Medical Systems has a date with the FDA tomorrow, when the agency’s expert Anesthesiology & Respiratory Therapy Devices Panel will review data and make a recommendation on the Inspire II Upper Airway Stimulator.
FDA to review Inspire Medical’s sleep apnea implant
Inspire Medical Systems is getting the FDA treatment, landing a date next month with the Anesthesiology & Respiratory Therapy Devices panel to undergo review of the company’s implanted Inspire II Upper Airway Stimulator for treatment of obstructive sleep apnea.
MassDevice Network
@MassDevice
LinkedIn
Google+